Latest News about PFE
Recent news which mentions PFE
3 No-Brainer Stocks to Buy With $50 Right Now
October 31, 2023
From Motley Fool
S&P 500 futures steady as lower Treasury yields support sentiment
October 31, 2023
From MarketWatch
From Benzinga
Pfizer, AMD And 3 Stocks To Watch Heading Into Tuesday
October 31, 2023
From Benzinga
7 Low-Risk Stock Picks to Double Your Money
October 30, 2023
Tags
STNE
NASDAQ:MELI,NASDAQ:AMZN,NYSE:DIS,NASDAQ:STNE,NASDAQ:LNTH,NYSE:PFE,NASDAQ:TEAM,NYSE:NEE
AMZN
From InvestorPlace
Monday's Market Minute: Fed In Focus This Week, But Plenty Of Earnings & Data As Well
October 30, 2023
From Benzinga
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
October 30, 2023
From Benzinga
The market’s in a funk. Why now is an attractive entry point for long-term investors, says JPMorgan strategist.
October 30, 2023
From MarketWatch
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
From Benzinga
The 7 Most Undervalued Long-Term Stocks to Buy: October 2023
October 29, 2023
From InvestorPlace
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
From Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
October 28, 2023
From Motley Fool
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
October 27, 2023
From Benzinga
From InvestorPlace
FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie
October 27, 2023
From Benzinga
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
October 27, 2023
From InvestorPlace
The 7 Most Undervalued Dividend Stocks to Buy: October 2023
October 27, 2023
From InvestorPlace
7 Undervalued Stocks That Analysts Love Right Now
October 26, 2023
From InvestorPlace
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 25, 2023
From Benzinga
Pfizer's Dividend Yield Is Now 5%. Is the Stock a No-Brainer Buy for Income Investors?
October 25, 2023
Tickers
PFE
From Motley Fool
Is BioNTech Stock a Buy Now?
October 25, 2023
From Motley Fool
From Motley Fool
Moderna’s stock suffering record losing streak as ‘investor caution remains high’ over COVID vaccine sales
October 23, 2023
From MarketWatch
Why Is Roivant Sciences (ROIV) Stock Up Today?
October 23, 2023
From InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
October 23, 2023
From Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
October 23, 2023
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.